Company / Gross Profit
Neogen Gross Profit History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$421.4M
FY2024
5-year range
$243.0M / $463.9M
FY2020-FY2024
Trend
-9.2%
vs FY2023
Sector context
#61 of 95
Health Care
What the data says
At $421M, Neogen's gross profit ranks #61 of 95 in the Health Care sector. Improved from $406M to $421M over the past 2 years.
Based on SEC 10-K filings.
$421M in FY2024 with a 5-year CAGR of +16.5%.
Improved from $406M to $421M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +20.1%
- 5-Year CAGR
- +16.5%
- 10-Year CAGR
- -
Sector benchmark
#61 of 95 in Health CareTop 64% of 95This company $421.4M Sector average $1.9B
▼
-77.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.5%, indicating consistent growth.
- In FY2024, gross profit decreased 9.2% year-over-year.
- Ranks #61 out of 95 companies in the Health Care sector.
- Peak gross profit was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $421.4M | -9.2% |
| FY2023 | $463.9M | +14.3% |
| FY2022 | $406.0M | +67.1% |
| FY2021 | $243.0M | +13.0% |
| FY2020 | $215.1M | +9.6% |
| FY2019 | $196.3M | +2.3% |
| FY2018 | $191.9M | +3.0% |
| FY2017 | $186.3M | +10.3% |
| FY2016 | $168.9M | +10.4% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026